GLP-1 Peptide weight loss faqs

---

Semaglutide, Tirzepatide and Retatrutide belong to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs. They mimic the GLP-1 hormone released in the gut in response to eating. GLP-1 in higher amounts also interacts with the parts of the brain that suppress your appetite and signal you to feel full. When used in conjunction with diet and exercise, Semaglutide, Tirzepatide, and Retatrutide can cause significant weight loss!

DO NOT take GLP-1s if you have a familial or personal history of Thyroid Cancer.

DO NOT take GLP-1s if you have Multiple Endocrine Neoplasia syndrome type 2.

DO NOT take GLP-1s if you have a history of Pancreatitis.

DO NOT take GLP-1s if you are pregnant or planning to become pregnant.

Tell your provider if you are Diabetic or take medications for Diabetes.

People taking GLP-1s for weight loss may experience:

• Dizziness
• Fatigue
• Headache
• Gastrointestinal issues, such as diarrhea, constipation and gassiness
• Stomach issues, including nausea, vomiting, pain or distention (bloat)

Gastrointestinal issues are the most common complaint among people just starting GLP-1s. Side effects will decrease over time.

At Aglow we are providing a consultation as well as weekly injections for Semaglutide starting at  $179 per  month and for Tirzepatide or Retatrutide starting at $300 per month.

Studies show patients on a regular dosing schedule lose 6-9 pounds in the first month.

With monthly dosage increases, weight loss increases. 

For the best weight loss results, it is recommended to get GLP-1s once a week for a minimum of 5 months.